No profile data available.
Curis, Inc. (CRIS) is a healthcare company in the additional cancer treatment drugs industry, based in Lexington, United States, with about 20 full-time employees.
It reported revenue of $9.44 million for fiscal year 2025, down 13.4% from fiscal year 2024, and net income of -$7.58 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0, down 100.0% from a year before. Its market capitalization was $1.63 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.
Curis reported $9.44 million in revenue for fiscal year 2025, down 13.4% from $10.91 million in fiscal year 2024. In Q2 2026 revenue was $0.
$1.63 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Genprex, Inc. (GNPX), Purple Biotech Ltd (PPBT), Carisma Therapeutics, Inc. (CARM), Marijuana Inc. (MAJI).